Intelligent Investor

Oventus Medical Limited (ASX: OVN) - Share Price and Research

DELISTED - Current share price for OVN : $0.020

OVN General Information +

ASX Code OVN
Website N/A
Industry/Sector Health Care Equipment
Market Cap ($M) n/a
OVN Share Price $0.020
Day High $0.020
Day Low $0.019
Last Close $0.020
OVN Share Price Movement - ( No change )
Prices as at 16:35, 24 Jul 2023
+Security prices are delayed by at least 20 minutes and are indicative only.
Upsell Banner

OVN Related Research

Oventus Medical Limited (OVN) Upcoming Dividends & Yields

There are no dividends for Oventus Medical Limited (OVN). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Oventus Medical Limited (OVN) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Removal from Official List 21 Jul 2023 10:29AM $0.020 $0.020 $0.020 fallen by 0%
Delisting of Oventus Medical Limited 17 Jul 2023 6:21PM $0.020 $0.020 $0.020 fallen by 0%
Market Update 20 Feb 2023 2:16PM $0.020 $0.020 $0.020 fallen by 0%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from Oventus Medical Limited (OVN) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

OVN Directors

Name Position Start Date
Mr Jason (Jake) Nunn Non-Executive Director 25 Feb 2020
Mr Paul Molloy Non-Executive Director 16 Dec 2019
Ms Sue(Susan) MacLeman Non-Executive Director, Non-Executive Chairman 27 Nov 2015

Oventus Medical Limited (OVN) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
13 Oct 2021 BRIDGES, Melvyn Buy Indirect Shares 82,877 $0.120 $9,945.240
22 Sep 2021 BRIDGES, Melvyn Buy Indirect Shares 1,300,000 $0.111 $144,772.230
10 Sep 2021 MACLEMAN, Sue Buy Indirect Shares 86,956 $0.116 $10,126.430

See all changes in directors' interest & trades for Oventus Medical Limited (OVN) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

OVN Management

Name Position
John Cox Chief Executive Officer
James Hunter Chief Financial Officer
John Cox Chief Operating Officer
Stephen (Steve) Denaro Company Secretary

OVN Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (OVN). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
48,107,416 (19.90%) Thorney technologies Ltd
27,542,517 (11.39%) Christopher Patrick Hart

FAQs about Oventus Medical Limited (OVN)

Oventus Medical Limited's (OVN) current share price is $0.02. This constitutes a price movement of 0% when compared to the share price 7 days ago and is 0% below OVN's 12-month high of $0.02 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $0.02, Oventus Medical Limited's (OVN) current share price of $0.02 constitutes a movement of or 0%. Oventus Medical Limited's (OVN) share price movement is 0% when compared to 7 days ago and is 0% below OVN's 52-week high of $0.02.

Oventus Medical Limited's (OVN) 52-week high is $0.02 which was reached on 18 Apr 2023. Relative to this, OVN's current share price of $0.02 constitutes a or 0% drop since that high of $0.02 per OVN share.

Oventus Medical Limited's (OVN) 52-week low is $0.02 which was reached on 18 Apr 2023. Relative to this, OVN's current share price of $0.02 constitutes a or 0% drop since that low of $0.02 per OVN share.

Over the last 12 months, Oventus Medical Limited (OVN) has a daily average trading volume of 10,791 OVN shares per day.

Oventus Medical Limited (OVN) will release its next Annual Report on n/a. Oventus Medical Limited's (OVN) last annual report was released on 15 Oct 2021. Click here to view Oventus Medical Limited's (OVN) last annual report.

Oventus Medical Limited (OVN) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.